Inflammatory Myopathy Associated with Anti-mitochondrial Antibody-negative Primary Biliary Cholangitis Diagnosed by a Liver Biopsy

Intern Med. 2023 Mar 1;62(5):797-802. doi: 10.2169/internalmedicine.9666-22. Epub 2022 Aug 10.

Abstract

Anti-mitochondrial antibody (AMA)-associated myopathies represent a homogeneous disease entity with severe arrhythmia and slowly progressive proximal muscle weakness with lordotic posture, irrespective of the presence of primary biliary cholangitis (PBC). We herein report a case of myositis associated with PBC without AMAs. A 48-year-old woman presented with clinical features very similar to AMA-associated myositis, despite negative AMAs. PBC, ascertained by a liver biopsy performed based on mildly elevated liver enzymes, and the efficacy of steroid therapy on muscle weakness confirmed the diagnosis of immune-mediated myositis. When AMAs are negative, a liver biopsy is indispensable for diagnosing treatable PBC-associated myositis.

Keywords: anti-mitochondrial antibodies (AMAs); arrhythmia; inflammatory myopathy; liver biopsy; lordotic posture; primary biliary cholangitis (PBC).

Publication types

  • Case Reports

MeSH terms

  • Autoantibodies
  • Biopsy
  • Cholangitis*
  • Cytarabine
  • Female
  • Humans
  • Liver Cirrhosis, Biliary* / diagnosis
  • Middle Aged
  • Myositis*

Substances

  • Autoantibodies
  • Cytarabine